IL134156A0 - Alatrofloxacin parenteral compositions - Google Patents

Alatrofloxacin parenteral compositions

Info

Publication number
IL134156A0
IL134156A0 IL13415698A IL13415698A IL134156A0 IL 134156 A0 IL134156 A0 IL 134156A0 IL 13415698 A IL13415698 A IL 13415698A IL 13415698 A IL13415698 A IL 13415698A IL 134156 A0 IL134156 A0 IL 134156A0
Authority
IL
Israel
Prior art keywords
alatrofloxacin
parenteral compositions
parenteral
compositions
alatrofloxacin parenteral
Prior art date
Application number
IL13415698A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL134156A0 publication Critical patent/IL134156A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13415698A 1997-08-01 1998-07-23 Alatrofloxacin parenteral compositions IL134156A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01
PCT/IB1998/001122 WO1999006430A1 (en) 1997-08-01 1998-07-23 Alatrofloxacin parenteral compositions

Publications (1)

Publication Number Publication Date
IL134156A0 true IL134156A0 (en) 2001-04-30

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13415698A IL134156A0 (en) 1997-08-01 1998-07-23 Alatrofloxacin parenteral compositions

Country Status (40)

Country Link
US (1) US6194429B1 (xx)
EP (1) EP1000086B1 (xx)
JP (1) JP3463928B2 (xx)
KR (1) KR20010022495A (xx)
CN (1) CN1265671A (xx)
AP (1) AP1031A (xx)
AR (1) AR015417A1 (xx)
AT (1) ATE259827T1 (xx)
AU (1) AU734863B2 (xx)
BG (1) BG104105A (xx)
BR (1) BR9811580A (xx)
CA (1) CA2296466C (xx)
CO (1) CO4970688A1 (xx)
DE (1) DE69821767T2 (xx)
DK (1) DK1000086T3 (xx)
DZ (1) DZ2576A1 (xx)
EA (1) EA002120B1 (xx)
ES (1) ES2214716T3 (xx)
GT (1) GT199800112A (xx)
HN (1) HN1998000106A (xx)
HR (1) HRP980417B1 (xx)
HU (1) HUP0004793A3 (xx)
ID (1) ID24374A (xx)
IL (1) IL134156A0 (xx)
IS (1) IS5339A (xx)
MA (1) MA24626A1 (xx)
NO (1) NO20000485L (xx)
NZ (1) NZ502249A (xx)
OA (1) OA11281A (xx)
PA (1) PA8456701A1 (xx)
PE (1) PE103799A1 (xx)
PL (1) PL338477A1 (xx)
PT (1) PT1000086E (xx)
SK (1) SK1012000A3 (xx)
TN (1) TNSN98146A1 (xx)
TW (1) TW538043B (xx)
UY (1) UY25113A1 (xx)
WO (1) WO1999006430A1 (xx)
YU (1) YU2500A (xx)
ZA (1) ZA986874B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230030B1 (hu) * 1999-10-08 2015-05-28 Debiopharm International Sa Fab I inhibitorok
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
CA2444597A1 (en) 2001-04-06 2002-10-06 Affinium Pharmaceuticals, Inc. Fab i inhibitors
SI1575951T1 (sl) * 2002-12-06 2014-10-30 Debiopharm International Sa Forum "Apres-Demain" Heterociklične spojine, postopki za njihovo izdelavo in njihova uporaba v terapiji
WO2004082586A2 (en) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
PL1828167T3 (pl) 2004-06-04 2015-02-27 Debiopharm Int Sa Pochodne akryloamidu jako środki antybiotykowe
KR20080075027A (ko) * 2005-12-05 2008-08-13 아피늄 파마슈티컬스, 인크. Ｆａｂｉ 억제제 및 항박테리아제로서의헤테로시클릴아크릴아미드 화합물
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
SG11201408100YA (en) 2012-06-19 2015-01-29 Debiopharm Int Sa Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
CA2946413A1 (en) * 2014-04-25 2015-10-29 Naurex, Inc. Stable compositions of neuroactive peptides
MA43697B1 (fr) 2016-02-26 2021-01-29 Debiopharm Int Sa Médicament pour le traitement des infections diabétiques du pied
WO2019148293A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Glass formulations comprising steroid dimers and uses thereof
JP2023524494A (ja) 2020-05-01 2023-06-12 リップル セラピューティクス コーポレーション 眼障害を処置するためのヘテロ二量体組成物と方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
HUT74883A (en) 1994-01-18 1997-02-28 Pfizer New process and intermediates for preparing naphthyridonecarboxylic acid salts
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
WO1996039406A1 (en) 1995-06-06 1996-12-12 Pfizer Inc. NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
WO1997000268A1 (en) 1995-06-15 1997-01-03 Pfizer Inc. Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
PL185709B1 (pl) 1995-08-29 2003-07-31 Pfizer Nowy monohydrat polimorfu II 6-N-(L-Ala-L-Ala)-trowafloksacyny i środek farmaceutyczny
JP3188476B2 (ja) 1995-08-29 2001-07-16 ファイザー・インコーポレーテッド 両性イオン形トロバフロキサシン
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
ATE259827T1 (de) 2004-03-15
EA002120B1 (ru) 2001-12-24
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
JP2001512133A (ja) 2001-08-21
PT1000086E (pt) 2004-05-31
HN1998000106A (es) 1999-01-08
UY25113A1 (es) 2000-12-29
CN1265671A (zh) 2000-09-06
DE69821767D1 (de) 2004-03-25
YU2500A (sh) 2002-09-19
BG104105A (bg) 2000-08-31
NO20000485D0 (no) 2000-01-31
NZ502249A (en) 2001-11-30
TNSN98146A1 (fr) 2005-03-15
PA8456701A1 (es) 2000-05-24
BR9811580A (pt) 2000-08-22
HUP0004793A2 (hu) 2001-04-28
AP9801310A0 (en) 1998-09-30
AU8236898A (en) 1999-02-22
US6194429B1 (en) 2001-02-27
AU734863B2 (en) 2001-06-21
MA24626A1 (fr) 1999-04-01
DZ2576A1 (fr) 2003-02-22
AR015417A1 (es) 2001-05-02
AP1031A (en) 2001-12-21
IS5339A (is) 2000-01-14
EP1000086B1 (en) 2004-02-18
ID24374A (id) 2000-07-13
HRP980417B1 (en) 2002-10-31
KR20010022495A (ko) 2001-03-15
GT199800112A (es) 2000-01-15
SK1012000A3 (en) 2000-09-12
HUP0004793A3 (en) 2001-10-29
HRP980417A2 (en) 1999-08-31
OA11281A (en) 2002-11-19
DK1000086T3 (da) 2004-05-17
ZA986874B (en) 2000-01-31
EP1000086A1 (en) 2000-05-17
CO4970688A1 (es) 2000-11-07
NO20000485L (no) 2000-03-27
WO1999006430A1 (en) 1999-02-11
EA200000086A1 (ru) 2000-08-28
JP3463928B2 (ja) 2003-11-05
ES2214716T3 (es) 2004-09-16
CA2296466C (en) 2003-04-15
DE69821767T2 (de) 2005-01-13
PE103799A1 (es) 1999-10-25
CA2296466A1 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
HUP9903759A3 (en) Abtimicrobial compositions
GB9726814D0 (en) Compositions
GB9702238D0 (en) Compositions
GB9704524D0 (en) Composition
IL134156A0 (en) Alatrofloxacin parenteral compositions
GB9716152D0 (en) Improved table
IL130856A0 (en) Peroxetine compositions
GB9726543D0 (en) Novel compositions
PL336038A1 (en) Pharmaceutic compositions
PL338017A1 (en) Novel composition
EP0958806A4 (en) HAIR COLORING COMPOSITION
GB9724838D0 (en) Compositions
GB9701031D0 (en) Composition
GB9705340D0 (en) Compositions
GB9703109D0 (en) Compositions
PL335729A1 (en) Pharmaceutic compositions
GB9705813D0 (en) Novel compositions
GB9712981D0 (en) Compositions
GB2336368B (en) Compositions
GB9708467D0 (en) Compositions
GB9705413D0 (en) Compositions
GB9719640D0 (en) Compositions
GB9703375D0 (en) Compositions
GB9722734D0 (en) Compositions
GB9703611D0 (en) Compositions